Haas Jason
- SEC CIK
- 0001883821
In the past year, 1 open-market purchase filing worth $20.0K and 2 sale filings worth $3.74M.
Current role at each company
- LGND Ligand Pharmaceuticals IncDirectoras of Aug 14, 2026
- ODTX Odyssey Therapeutics, Inc.Chief Financial Officeras of May 11, 2026
- SYRS Syros Pharmaceuticals, Inc.Chief Financial Officeras of Nov 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $20.0K
- 1 filing
- Sold
- $3.74M
- 2 filings
- Net
- −$3.72M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Haas Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LGND Ligand Pharmaceuticals Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Haas JasonDirector | SSale | −6.46K | $255.58 | −$1.65M | −56.5%4.98K after | 2 lots |
| Aug 14, 2026 (view filing)5:04 PM ET | Aug 12 | 2 days | Haas JasonDirector | SSale | −7.14K | $292.81 | −$2.09M | −64.2%3.98K after |
ODTX Odyssey Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing) | May 8 | 3 days | Haas JasonChief Financial Officer | PPurchase | +1.00K | $20.00 | +$20.0K | +1.6%62.9K after |
SYRS Syros Pharmaceuticals, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 (view filing) | Sep 10-12 | 2 days | Haas JasonChief Financial Officer | PPurchase | +100.0K | $1.61 | +$161.5K | +407.3%124.6K after | 3 lots |
| Nov 20, 2024 (view filing)5:00 PM ET | Nov 18 | 2 days | Haas JasonChief Financial Officer | SSale | −137.8K | $0.2103 | −$29.0K | −100.0%0 after |